RYTM FY 2020 Earnings — Rhythm Pharmaceuticals, Inc. Revenue & Financial Results | Market Cap Arena

RYTMRhythm Pharmaceuticals, Inc.

$6B

FY 2020 Earnings

Healthcare Biotechnology

Income Statement

Revenue

$0

Gross Profit

-$690,000

Operating Income

-$137M

Net Income

-$131M

EPS (Diluted)

$-2.96

Cash Flow

Operating Cash Flow

-$122M

Free Cash Flow

-$122M

Stock-Based Comp.

$17M

Balance Sheet

Total Assets

$187M

Total Liabilities

$21M

Stockholders' Equity

$167M

Cash & Equivalents

$101M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$0	$0	—
Gross Profit	-$690,000	-$834,000	+17.3%
Operating Income	-$137M	-$146M	+6.5%
Net Income	-$131M	-$135M	+2.9%